Literature DB >> 34344280

Bilateral Multifocal Choroiditis following COVID-19 Vaccination.

Mallika Goyal1, Somasheila I Murthy2, Sridhar Annum1.   

Abstract

Purpose: To report a case of bilateral choroiditis following COVID-19 vaccination.Study Design: Case report.
Results: A 34-year old male presented with visual loss one week after the second dose of COVID-19 vaccine. Examination showed large serous detachment of the macula in the right eye and severe choroidal thickening noted on ultrasonography in both eyes. The patient's condition improved rapidly with oral corticosteroids with significant resolution of the serous detachments within two weeks of initiating treatment and complete visual recovery subsequently.Conclusions: The onset of ocular symptoms starting within one week following vaccination suggests an inflammatory or autoimmune response to the vaccine. Ophthalmologists should consider the option of autoimmune and other inflammatory ocular problems, which may manifest as uveitis, following COVID-19 vaccination. Timely diagnosis and treatment with corticosteroids can result in good visual and structural outcome.

Entities:  

Keywords:  COVID-19; COVID-19 vaccination; Covishield vaccine; choroiditis following vaccination; uveitis following vaccination

Mesh:

Substances:

Year:  2021        PMID: 34344280     DOI: 10.1080/09273948.2021.1957123

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  19 in total

1.  Incidence of COVID-19 Vaccination-Related Uveitis and Effects of Booster Dose in a Tertiary Uveitis Referral Center.

Authors:  Milton C Chew; Shaan Wiryasaputra; Meihui Wu; Wei Boon Khor; Anita S Y Chan
Journal:  Front Med (Lausanne)       Date:  2022-06-22

Review 2.  Ocular Manifestations after Receiving COVID-19 Vaccine: A Systematic Review.

Authors:  Yu-Kuei Lee; Yi-Hsun Huang
Journal:  Vaccines (Basel)       Date:  2021-11-27

Review 3.  Ocular and Systemic Complications of COVID-19: Impact on Patients and Healthcare.

Authors:  Ella H Leung; Jason Fan; Harry W Flynn; Thomas A Albini
Journal:  Clin Ophthalmol       Date:  2022-01-04

Review 4.  After the Storm: Ophthalmic Manifestations of COVID-19 Vaccines.

Authors:  Mrittika Sen; Santosh G Honavar
Journal:  Indian J Ophthalmol       Date:  2021-12       Impact factor: 2.969

Review 5.  Ocular Complications Following Vaccination for COVID-19: A One-Year Retrospective.

Authors:  Abid A Haseeb; Omar Solyman; Mokhtar M Abushanab; Ahmed S Abo Obaia; Abdelrahman M Elhusseiny
Journal:  Vaccines (Basel)       Date:  2022-02-21

6.  Severe panuveitis with iridis rubeosis activation and cystoid macular edema after BioNTech-Pfizer COVID-19 vaccination in a 17-year-old.

Authors:  Asaf Achiron; Raimo Tuuminen
Journal:  Am J Ophthalmol Case Rep       Date:  2022-01-30

7.  Multiple evanescent white dot syndrome following BNT162b2 mRNA COVID-19 vaccination.

Authors:  Eriko Yasuda; Wataru Matsumiya; Yoshifumi Maeda; Sentaro Kusuhara; Quan Dong Nguyen; Makoto Nakamura; Rumiko Hara
Journal:  Am J Ophthalmol Case Rep       Date:  2022-04-10

Review 8.  COVID-19 mRNA Vaccine-Associated Uveitis Leading to Diagnosis of Sarcoidosis: Case Report and Review of Literature.

Authors:  Toshihiko Matsuo; Hiroyuki Honda; Takehiro Tanaka; Kensuke Uraguchi; Masaaki Kawahara; Hideharu Hagiya
Journal:  J Investig Med High Impact Case Rep       Date:  2022 Jan-Dec

9.  Paracentral acute middle maculopathy and COVID-19 vaccination: Causation versus coincidence finding.

Authors:  Alireza Dehghani; Heshmatollah Ghanbari; Mohammad-Hossein Houshang-Jahromi; Mohsen Pourazizi
Journal:  Clin Case Rep       Date:  2022-03-13

10.  Uveitis and Other Ocular Complications Following COVID-19 Vaccination.

Authors:  Elena Bolletta; Danilo Iannetta; Valentina Mastrofilippo; Luca De Simone; Fabrizio Gozzi; Stefania Croci; Martina Bonacini; Lucia Belloni; Alessandro Zerbini; Chantal Adani; Luigi Fontana; Carlo Salvarani; Luca Cimino
Journal:  J Clin Med       Date:  2021-12-19       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.